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snoRNAs are functional, noncoding
RNAs usually transcribed by RNA
Polymerase II, the same enzyme that
synthesises messenger RNAs. In con-
trast to mRNAs, snoRNAs are ribonu-
cleolytically processed to achieve
functionality.
snoRNA processing aims to erase
mRNA hallmarks: the m7G cap and
the poly(A) tail. Different snoRNA
maturation strategies are employed
depending on organism and genomicTranscribing RNA Polymerase II interacts with multiple factors that orchestrate
maturation and stabilisation of messenger RNA. For the majority of noncoding
RNAs, the polymerase complex employs entirely different strategies, which
usually direct the nascent transcript to ribonucleolytic degradation. However,
some noncoding RNA classes use endo- and exonucleases to achieve func-
tionality. Here we review processing of small nucleolar RNAs that are tran-
scribed by RNA Polymerase II as precursors, and whose 50 and 30 ends undergo
processing to release mature, functional molecules. The maturation strategies
of these noncoding RNAs in various organisms follow a similar pattern but
employ different factors and are strictly correlated with genomic organisation of
their genes.organisation of snoRNA genes.
ncRNA-speciﬁc transcription termina-
tion factors recruit 30 end processing
exonucleases to independently tran-
scribed pre-snoRNAs.
Removal of the m7G cap is crucial for
box C/D snoRNAs maturation and
functionality in S. cerevisiae.
Alternative snoRNA processing may
generate noncanonical functional
snoRNAs.
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Grzechnik).Small Nucleolar RNAs: Essential and Functional Noncoding RNAs
During the past decade, it has become apparent that RNAs transcribed from noncoding
regions of the genome play essential functions in various biological processes. This prompted
researchers to gain an understanding of how noncoding RNA (ncRNA) biogenesis is controlled
and whether (and how) this process resembles synthesis of messenger RNA (mRNA). Recent
analyses of small nucleolar RNAs (snoRNAs) have provided fundamental information on how
expression of these ncRNAs is regulated. SnoRNAs are essential, short (60–300 nt long),
mostly nucleoli-localised, non-polyadenylated ncRNAs, present in all eukaryotic organisms.
They are classiﬁed by the presence of highly conserved sequences (‘boxes’), as either box C/D
or box H/ACA (Figure 1A). The box C/D snoRNAs form a closed loop, which contains a box C
and a box D (with conserved RUGAUGA and CUGA motifs, respectively), as well as a less
conserved box C0 and box D0 [1]. The box H/ACA snoRNAs usually consist of two stem loops
linked by the H box (ANANNA motif) and an ACA sequence near the 30 end [1]. Box C/D
snoRNAs with a long UG repeat and H/ACA snoRNAs with an additional CAB box (UGAG motif)
are called small Cajal body-associated RNAs (scaRNA) (Figure 1A) and are localised in
subnuclear structures known as Cajal bodies [2,3]. Both snoRNA classes are bound by a
distinct set of proteins to form stable and catalytically active box C/D and box H/ACA
ribonucleoprotein (snoRNP) structures [4].
The majority of snoRNAs carry speciﬁc sequences, which are complementary to other cellular
RNAs and thus guide snoRNP to speciﬁc RNA substrates. The main function of canonical
snoRNAs and scaRNAs is 2-O0-methylation (box C/D) and pseudouridylation (box H/ACA) of
ribosomal RNA (rRNA) and small nuclear RNAs (snRNA), respectively (Figure 1A) [1]. A number
of snoRNAs also directly participate in the nucleolytic processing of rRNA precursors [5].
However, a large subclass of snoRNAs called orphan snoRNAs appears not to match any other
RNA sequence [6]. Higher organisms also encode many noncanonical snoRNAs that may lack
speciﬁc boxes, may be shortened or extended, or may contain both C/D and H/ACA boxes [6–
9]. Although expression of many of these unusual snoRNAs is yet to be conﬁrmed, they are
likely to have alternative regulatory functions, for example, in pre-mRNA splicing [7,8] or
regulation of polyadenylation site (PAS) recognition via direct snoRNA interaction with the104 Trends in Genetics, February 2019, Vol. 35, No. 2 https://doi.org/10.1016/j.tig.2018.11.005
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
snoRNA C/D
Unknown
funcon 
H ACA H ACA
CAB CAB
G/U
scaRNA C/D             scaRNA H/ACA
rRNA
2ʹ-O -Me
2ʹO -Me
snRNA
(A)
(B) (C)
Exon 1 Exon 2 Exon 3snR snRsnR
Exon 1 Exon 2 Exon 3
snR snR
snR snRsnR
Exon 1 Exon 3
snRP T
snRP TsnR snR
Exon 1 Exon 2snR
Independent
Polycistronic
Intronic
Splicing
Alternave
splicing 
snoRNA H/ACA
C
D’
D
C’
C
D’
D
C’
Figure 1. Classes and Genomic Organisation of Small Nucleolar RNAs (snoRNAs). (A) snoRNA classes and
functions. Conserved consensus sequences (boxes) are shown as rectangles. 20-O-Me: box C/D-dependent methylation;
C: box H/ACA-dependent pseudouridylation. (B) Genomic organisation of snoRNA genes changes with increasing
organism complexity. (C) Alternative splicing regulates expression of snoRNA genes located within the same host
molecule. snoRNA, which partially overlaps with Exon 2, is not expressed when all exons are spliced. Exon 2 skipping
generates an snoRNA-containing lariat, the processing of which releases all three snoRNAs. Exon, mRNA or lncRNA
exons; P, promoter; scaRNA, small Cajal body-associated RNA; T, terminator.mRNA cleavage and polyadenylation (CPA) machinery [10]. snoRNAs may also affect cellular
processes indirectly, by disturbing ribosome and snRNA formation, which as a result may
control expression of protein-coding genes via splicing and translation efﬁciency [11,12].
Another indirect regulatory level is provided by snoRNAs that are processed to shorter micro-
RNAs (miRNAs) [9] or Piwi-interacting RNAs (piRNAs), which act in gene silencing pathways
[13].
The number of snoRNA genes increases with organism complexity. For example, in the yeast
Saccharomyces cerevisiae, 64 transcription units encode 76 snoRNAs [14]. In humans, it is
estimated that there are 550 snoRNAs; however, in silico analyses predict that the total
number of different types of snoRNAs may exceed 1000 [6,15]. Strikingly, genomic organisa-
tion of snoRNA genes also follows the evolutionary tree (Figure 1B). S. cerevisiae snoRNAs are
mainly transcribed from independent genes; however, very few are organised in polycistrons
(17 snoRNAs localised in 5 clusters) or are embedded in mRNA introns (8 snoRNAs) [14]. In
Drosophila melanogaster and Caenorhabditis elegans, snoRNAs are less frequently tran-
scribed as single units and are mostly organised in polycistrons [1]. In humans, snoRNA genes
are predominantly located within mRNA or long noncoding RNA (lncRNA) introns and released
from the host precursor by splicing [1,16]. However, snoRNA synthesis does not necessarilyTrends in Genetics, February 2019, Vol. 35, No. 2 105
correlate with the expression of mRNA of the host genes. Up to 96% of 173 transcribed
snoRNA host genes in human cells frequently produce mRNA or lncRNA isoforms that are
directed to degradation via nonsense-mediated RNA decay (NMD) [17]. This suggests that at
least some snoRNA hosting mRNAs and lncRNAs are nonfunctional and are transcribed and
spliced only to release intronic snoRNAs. Also, in the case of multi-snoRNA hosts, some
snoRNA genes are located fully or partially within their exons. Many isoforms generated by
alternative splicing of such transcripts become NMD substrates, allowing for selective expres-
sion of intronic snoRNAs, but not those located in exons [17]. This illustrates that snoRNA
accumulation can be regulated independently from the level of the host RNA or other snoRNAs
within the same transcription unit (Figure 1C).
snoRNA Maturation Pathways
snoRNA genes are usually transcribed by RNA Polymerase II (Pol II), which also synthesises
mRNAs. However, in contrast to mRNAs, which are exported to the cytoplasm and translated,
snoRNAs remain in the nucleus [1,18,19]. This may be facilitated by the lack of mRNA structural
hallmarks: the m7G cap bound by the cap-binding complex (CBC) and the poly(A) tail, which
both enhance export to the cytoplasm. These mRNA-speciﬁc elements are removed by
snoRNA maturation. Indeed, in S. cerevisiae, snoRNAs that retain an mRNA-like 50 end are
exported from the nucleus [20].
The general outline of snoRNA processing follows the same course for all classes in all
organisms: newly synthesised pre-snoRNAs are trimmed by ribonucleases at 30 or both 50
and 30 ends. As a result, 50 and 30 RNA regions that are not protected by cotranscriptionally
associated snoRNP proteins or RNA secondary structures, are removed. In cases where the
transcription start site (TSS) deﬁnes the mature 50 end, the cap is retained on snoRNA and is
post-transcriptionally modiﬁed (see below).
snoRNA 30 End Processing in S. cerevisiae
The 30 end processing, coupled with transcription termination, is one of the most important
processes deﬁning an RNA precursor as either mRNA or ncRNA. In eukaryotic cells, mRNA-
speciﬁc transcription termination and 30 end processing, mediated by the CPA complex, lead to
mRNA stabilisation (Box 1), while short noncoding genes employ mechanisms which couple
transcription termination with 30-50 degradation [21,22].
snoRNA 30 end formation is determined by genomic organisation and employs different factors
in various organisms (Figure 2, Key Figure). In S. cerevisiae, transcription termination of
independently transcribed snoRNAs is mediated by the ncRNA-speciﬁc NNS (Nrd1-Nab3-
Sen1) complex (Figure 2A), which consists of the RNA-binding proteins Nrd1 and Nab3 and the
RNA:DNA helicase Sen1 [22]. The NNS complex interacts with the Pol II C-terminal domain
(CTD) via the Nrd1 CTD-interacting domain (CID) and acts at a short distance (>1 kb) from the
TSS [23–25]. Transcription termination is initiated by binding of Nrd1 and Nab3 to NNS-binding
sites (NBS) (GUA[A/G] and UCUU[G], respectively) appearing in the nascent RNA [22,26,27].
This decreases the Pol II transcription rate downstream of NBS, which mirrors the process
observed for protein-coding genes downstream of PAS. Pol II is released from the DNA by the
helicase Sen1 in a mechanism that resembles Rho-dependent termination in bacteria [28].
Sen1 can both translocate along a single-stranded RNA or unwind short RNA:DNA hybrids in
vitro [28]. Thus, in vivo Sen1 may use either strategy to translocate towards Pol II and release it
from DNA by pulling the RNA from the polymerase catalytic centre. An analogous strategy may
be employed by the 50-30 exonuclease Rat1 (XRN2 in humans) for protein-coding genes (Box 1)
[21]. In addition to NNS, transcription termination of yeast ncRNA requires a number of mRNA-106 Trends in Genetics, February 2019, Vol. 35, No. 2
Box 1. Transcription Termination and 30 End Processing of Protein-Coding Genes
The mechanism of transcription termination and mRNA 30 end processing is conserved in eukaryotic organisms and
mediated by numerous factors, generally called the cleavage and polyadenylation (CPA) complex. In S. cerevisiae, the
central core of the CPA machinery is a multi-subunit cleavage and polyadenylation factor (CPF). Recent analysis
revealed that CPF consists of nuclease, poly(A) polymerase, and phosphatase modules [92]. The last module is also
present in the APT (associated with Pta1) complex, which is required for transcription termination of ncRNAs [29,32,93].
Transcription termination of protein-coding genes also requires additional subunits that cooperate with CPF: cleavage
factor IA containing the Pol II CTD-binding protein Pcf11, and cleavage factor IB. The human CPA complex is organised
in a similar manner. The cleavage and polyadenylation speciﬁcity factor (CPSF), which comprises RNA endonuclease
CPSF-73 and poly(A) polymerase PAP, is assisted by the cleavage stimulation factor (CstF) and cleavage factors I and II
(CFIm and CFIIm with PCF11) [94]. CPA is recruited to the transcribing polymerase complex at the 30 end of genes and
binds sequences that constitute the polyadenylation signal (PAS) in the nascent RNA. The CPF endonuclease CPSF-73
(Ysh1 in yeast) cleaves pre-mRNA 10–30 nt from the PAS (AAUAAA in humans) and the released transcript is
immediately polyadenylated at the 30 end by PAP (Pap1 in yeast) [21,93]. The cleavage at PAS has several con-
sequences. Pol II transcription rate signiﬁcantly decreases and the Pol II complex may undergo conformational changes,
which facilitate termination [95,96]. Moreover, the free 50 end of the nascent RNA provides an entry site for 50-30
exonuclease XRN2 (Rat1 in yeast). As a result, nascent RNA, which is generated by Pol II at a slow pace, is rapidly
digested in the 50 to 30 direction. XRN2/Rat1 pursues the transcribing complex and it is anticipated that the exonuclease
ﬁnally drags the RNA from Pol II. This may disrupt the DNA:RNA hybrid in the active centre and release Pol II from the
DNA template. The average distance of Pol II dissociation in humans is 3300 nt from the cleavage site and 160–190 nt in
yeast cells [97,98].speciﬁc CPA factors. These include the phosphatase module of the cleavage and polyade-
nylation factor (CPF, see Box 1), which together with Syc1 protein form the APT (associated
with Pta1) complex, and the component of the cleavage factor IA, CTD-interacting protein
Pcf11 [29–32]. While the exact contribution of APT to snoRNA termination is not fully under-
stood, Pcf11 has been extensively studied. Pcf11 is recruited to the transcribing complex
downstream of functional NBS clusters, which indicates that Pcf11 acts downstream of the
NNS complex in the termination process [31]. One scenario assumes that Pcf11 and CPA
components may employ AT-rich tracts in snoRNA terminators, thereby providing a fail-safe
mechanism [26]. Alternatively, Pcf11, either in the CPA complex or independently, collaborates
with NNS. The presence of Nrd1 at snoRNA terminators stimulates Pcf11 cotranscriptional
recruitment, which in turn displaces Nrd1 on the Pol II CTD [31]. This may further impair Pol II
transcription and facilitate Sen1-dependent termination, which requires the presence of Pcf11.
This option is supported by observations that Pcf11 mutation results in transcription termination
defects for snoRNAs, as well as in accumulation of RNA:DNA hybrids downstream of NNS
terminators [31]. The ﬁssion yeast Schizosaccharomyces pombe Nrd1 homologue Seb1
functionally resembles Pcf11 and is involved in transcription termination of both coding RNAs
and ncRNAs [33,34].
The NNS complex recruits 30 end processing factors (Figure 3A). First, pre-snoRNAs are
transiently oligoadenylated at the 30 end by the TRAMP complex [35,36]. In contrast to mRNA,
the adenine tail is short and used to attract exonucleases. The TRAMP poly(A) polymerase Trf4
binds Nrd1 through the Nrd1-interacting motif that mimics Pol II CTD [37]. The TRAMP complex
also recruits 30-50 processing enzymes (the exosome and its nuclear cofactor exonuclease
Rrp6 [37,38]), which exonucleolytically degrade pre-snoRNA until they encounter a formed
snoRNP [39]. In ﬁssion yeast, where NNS is not present, the exosome is recruited to pre-
snoRNAs via the poly(A)-binding protein Pab2 [40]. In a few cases (e.g., U3, snR40), the
endoribonuclease Rnt1 (RNase III) cleaves snoRNA precursors downstream of the mature
sequence, generating an entry site for exosome- and Rrp6-mediated processing [41,42].
Biogenesis of intronic snoRNAs in S. cerevisiae is not coupled to transcription termination, but
depends on splicing and snoRNA release by the intron-debranching factor Dbr1 or Rnt1Trends in Genetics, February 2019, Vol. 35, No. 2 107
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Figure 2. (A) Processing of individually transcribed snoRNAs. In Saccharomyces cerevisiae, snoRNAs are terminated by the Nrd1-Nab3-Sen1 (NNS) complex,
assisted by some cleavage and polyadenylation factors, including Pcf11. Factors and sequences mediating transcription termination in human cells remain mostly
unknown; however, the CPA factors and the Integrator complexes are possible candidates. The m7G cap is cotranscriptionally removed by Rnt1 from the majority of
box C/D pre-snoRNAs in S. cerevisiae, or post-transcriptionally converted to a 2,2,7-trimethylguanosine (TMG) cap for other snoRNAs. Unprotected snoRNA ends are
processed by exonucleases, Rat1 (50-30) and the nuclear exosome (30-50). Exonucleases advance along RNA until they are blocked by the snoRNP structure. (B) Intronic
snoRNAs are processed by exonucleases, mainly from spliced out and debranched introns. CPA, Cleavage and polyadenylation complex; NBS, NNS-binding site; P,
promoter; S.c., S. cerevisiae.cleavage (Figure 2B) [43–45]. Some snoRNAs (U24, snR38) strictly rely on splicing, while others
(U18, snR39, snR59) employ both splicing-dependent and Rnt1-mediated pathways. Follow-
ing the action of Dbr1 or Rnt1, 30 ends of pre-snoRNAs are processed exonucleolytically, but
the exosome and Rrp6 recruitment mode to these precursors has not been described. It is
possibly mediated by components of the NNS complex, Nrd1 and Nab3, which post-tran-
scriptionally bind many RNAs to mark them for exosome-dependent degradation [46]. In the
case of snoRNA clusters, individual snoRNAs are released from the polycistronic transcript by
Rnt1-mediated cleavage inbetween each snoRNA, whereas the last snoRNA undergoes
termination-dependent maturation similarly to independently transcribed snoRNAs [41,47,48].108 Trends in Genetics, February 2019, Vol. 35, No. 2
snoRNA 30 End Processing in Humans
In human cells only a small fraction of snoRNA genes are expressed as independent units
[1,49]. Although this includes essential U3, U8, U13, and telomerase snoRNA, their biogene-
sis has not been extensively studied. It is plausible that these snoRNAs may employ a
mechanism similar to other short ncRNAs (Figure 2A). Since the NNS complex is not present
in human cells, short ncRNAs, such as snoRNA-like snRNAs (Box 2), enhancer RNAs
(eRNAs), and promoter upstream transcripts (PROMPTs), are generally terminated by
CPA factors with a possible involvement of the 30 end processing Integrator complex
(Box 2). The Integrator promotes endonucleolytic cleavage of the nascent snRNA and eRNA,
resulting in their release from Pol II, which contributes to transcription termination [50–52]. In
addition to CPA and the Integrator, termination of ncRNAs requires a protein, ARS2, which
functionally resembles the yeast NNS complex and links transcription termination with 30 end
processing [53–55]. ARS2 is recruited to RNA by the CBC to form the CBCA complex, and
stimulates transcription termination of snRNAs, eRNAs, and PROMPTs in the proximity of the
TSS [54,55]. Although the interaction of CBCA with PHAX is essential for targeting of U3, U8,
and U13 snoRNAs to Cajal bodies [56], it is not clear whether CBCA is also involved in
snoRNA 30 end formation, since depletion of ARS2 and CBC does not affect transcription
termination of U8 snoRNA [54], The 30 end processing mode of independent snoRNAs raises
further questions. Their maturation may be carried out by the exosome that is recruited to
precursors by the NEXT complex, which forms the CBCN complex with CBCA via its
component ZC3H18 protein [53,57]. However, in the case of other short ncRNAs, NEXT
is excluded from RNA precursors by PHAX, which competes with ZC3H18 for CBCA binding
[58]. Alternatively, NEXT may be loaded on 30 unprocessed snoRNAs independently of CBC
via its RNA-binding protein RBM7. Such a mechanism has been observed for human intron-
encoded snoRNAs [58,59]. These intronic snoRNAs are processed exonucleolytically from
spliced and debranched introns or precursors released by endonucleolytic cleavages (Figures
2B and 3B) [60–63]. In both cases, RBM7 binds to long RNA 30 extensions, downstream of
mature RNAs, where it most likely recruits NEXT, thus marking these precursors for exosome-
dependent processing. It is also possible that individual and intronic pre-snoRNAs targeted
by RBM7/NEXT and the exosome are mainly subjected to complete degradation. Consis-
tently, snoRNA 30 end maturation has been reported to be mediated by deadenylases PARN
and TOE1 (Figure 3B), which remove poly(A) tails added post-transcriptionally by the PAPD5/
TRF4-2 component of the human TRAMP complex, and also trim redundant genome-
encoded residues [64–66]. PARN and TOE1 functions generally overlap, but PARN appears
to be more speciﬁc for 30 end processing of nucleolar-localised snoRNAs and telomerase
RNA, while TOE1 is engaged in 30 end formation of scaRNAs. Both deadenylases probably
compete with PAPD5 and the exosome to maintain the balance between processing and
degradation [65,66].
snoRNA 50 End Processing
Mature snoRNAs also differ from mRNAs at their 50 ends. The m7G cap is added cotranscrip-
tionally to every Pol II transcript, including individually transcribed snoRNAs, when the nascent
RNA is about 20–30 nt long [67]. However, pre-snoRNA 50 end processing either removes the
cap or converts the m7G to a 2,2,7-trimethylguanosine (TMG) cap (Figure 2A). S. cerevisiae
employs both strategies; TMG capping dominates for box H/ACA, while cap removal is more
often applied for maturation of box C/D snoRNAs [20,41,68]. In yeast, the majority of box C/D
snoRNAs are transcribed with a long (150–200 nt) 50 extension, which forms a stem loop
recognised and cleaved by the endonuclease Rnt1. The resulting unprotected 50 end is
attacked by the 50-30 exonucleases Rat1 and Xrn1 [41,68,69]. Both enzymes degrade pre-
cursors from the 50 end until they are blocked by the snoRNP structure.Trends in Genetics, February 2019, Vol. 35, No. 2 109
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Figure 3. Transition from Transcription to Small Nucleolar RNA (snoRNA) 30 End Processing. (A) The Nrd1-
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exclusively by deadenylases. S.c., S. cerevisiae.Rnt1 interacts with the NNS component Sen1, which suggests a crosstalk between 50 and 30
end processing [70]. Indeed, despite its activity at snoRNA 50 ends, Rnt1 is cotranscriptionally
recruited over their NNS terminators at the 30 ends [20]. Such a strategy allows for snoRNP
formation before the precursor is cleaved and so prevents premature 50-30 trimming, which may
lead to complete degradation of pre-snoRNA. Removal of the cap structure is required for
downstream processes in box C/D snoRNA synthesis. The 50 unprocessed box C/D pre-
snoRNAs have short, oligoadenylated unprocessed 30 ends and become exported from the
nucleus [20].110 Trends in Genetics, February 2019, Vol. 35, No. 2
Box 2. Maturation of snRNAs
snRNAs are regarded as the closest RNA family to snoRNAs as they are similarly stable, localised in the nucleus, and
share some processing strategies. Spliceosomal U1, U2, U4, and U5 snRNAs are synthesised by Pol II, unlike U6, which
is a Pol III transcript and its biogenesis follows a separate pathway. In all eukaryotes snRNAs are transcribed from
independent genes and are not processed at 50 ends and therefore their m7G caps are converted to the TMG cap by
Tgs1 [71]. In turn, the snRNA 30 end maturation pathway depends on the organism. In S. cerevisiae snRNAs are
terminated by the NNS complex and processed at the 30 end by the exosome and Rrp6 exonuclease, which resembles
the mechanism for independently transcribed snoRNAs [22]. Alternatively, as is the case for U3 snoRNA, snRNAs are
exonucleolytically processed from precursors generated by Rnt1 endonucleolytic cleavage downstream of their mature
ends and protected from degradation by binding of Lhp1, the homologue of human La protein [50]. The 30 end
processing is performed in the nucleus, but snRNA cap hypermethylation may also occur in the nucleolus, as U1 is
retained in this structure in the absence of Tgs1 [71]. Biogenesis of metazoan snRNAs is completely different. SnRNA
synthesis requires an snRNA-speciﬁc promoter, a conserved box in the 30 end region, and a large, 14 subunit Integrator
complex [50,51]. It seems that CPA factors that mediate transcription termination of human snRNAs have little, if any,
role in their 30 end processing. Instead, this pathway utilises the Integrator complex that is recruited to snRNA genes by
the Pol II CTD. Pre-snRNAs are cleaved at the 30 box by the Integrator subunit Int11, a paralogue of the CPA component
CPSF-73 [99]. The release of primary snRNA transcripts may promote Pol II transcription termination, as was shown for
eRNAs [52]. Cleaved snRNA intermediates are then exported from the nucleus to the cytoplasm via the CBC-bound
PHAX adaptor and the CRM1/RanGTP complex. The next steps that comprise exonucleolytic trimming by an unknown
nuclease, survival motor neuron (SMN), and protein arginine methyltransferase 5 (PRMT5), facilitates snRNP assembly
with the core Sm proteins and cap hypermethylation, which takes place in the cytoplasm. The assembled snRNPs are
imported back to the nucleus by TMG cap-bound snurportin-1 (SPN1) and importin b that probably interacts with the
SMN complex [100]. Finally, snRNAs are pseudouridylated and 20-O-methylated by scaRNAs in Cajal bodies.For the majority of yeast box H/ACA snoRNAs, the m7G cap is converted to a TMG cap by a
nucleolar trimethylguanosine synthetase Tgs1 [71]. Deletion of the TGS1 gene in S. cerevisiae
has no impact on snoRNA maturation, which indicates that cap hypermethylation does not
contribute to the crosstalk between both snoRNA ends [20,68]. The m7G cap conversion to a
TMG cap also occurs in higher organisms; however, the knowledge about this process in
snoRNA biogenesis is very limited. Tgs1 knockdown in human cells results in disruption of Cajal
bodies, but it is not clear if this is directly associated with snoRNA or snRNA synthesis, although
some steps of their formation take place in these structures [72]. Equally little is known about
the enzymes involved in 50 end trimming of vertebrate intronic snoRNAs, except that it is
performed by unspeciﬁed 50-30 exonuclease(s) [60,61].
Why snoRNAs are generally deprived of m7G caps by either genomic organisation or 50 end
processing is still to be explored. The m7G cap, an mRNA hallmark, may somehow counteract
processes that lead to the synthesis of box C/D snoRNPs. Indeed, in yeast cells lacking Rnt1,
box C/D snoRNAs with capped 50 extensions are mislocalised to the cytoplasm [20]. Conse-
quently, their activity in rRNA maturation is compromised, leading to hypomodiﬁed rRNA
subunits [20]. This in turn may impact ribosome biogenesis and regulation of its function
for optimal translation [73]. However, there might also be other aspects related to the status of
snoRNA 50 ends. Since the CBC complex promotes RNA degradation in the nucleus by Rat1/
Xrn1 and the exosome/Rrp6 [54,55,74], the persistent presence of CBC on mature m7G
capped snoRNAs may decrease their stability.
Different cellular fates of Pol II-generated snoRNA and mRNA transcripts are determined by
their distinct maturation pathways. Signals in the nascent transcripts or the sequence of
processing events classify the newly synthesised molecule as mRNA or snoRNA.Synthesis of Unusual snoRNA Classes
snoRNAs whose sequences differ from classical box C/D or box H/ACA layout may employ
speciﬁc processing strategies. For example, the snoRNA-like component of the humanTrends in Genetics, February 2019, Vol. 35, No. 2 111
telomerase (hTR) 30 region folds into a box H/ACA structure [75]. The 30 hairpin terminal stem
loop in this region contains an additional BIO motif, which is required for hTR 30 processing and
RNP assembly [76]. The BIO motif is also present in some AluACA RNAs, a subclass of human
box H/ACA RNPs that are processed from intronic Alu sequences [77,78]. AluACA RNAs
contain unusually short or long 50 hairpins that cannot support optimal snoRNP formation
required for snoRNA stability. As a result, these RNAs are very rapidly degraded. However,
AluACA RNAs, which contain the BIO motif, are stabilised by assembly into snoRNPs and
accumulate in Cajal bodies [77].
In human cells, snoRNAs may also exist as hybrids with lncRNAs. Two classes of such hybrids
are directly associated with Prader-Willi syndrome (PWS) [7,8] (Box 3). PWS results from the
loss of expression of genes from the q11–13 region of the paternally inherited chromosome 15,
which contains the snurf-snrp gene, and a downstream noncoding region considered primarily
as a snoRNA host gene [79]. The PWS-associated minimal 108 kb deletion of paternal
chromosome 15 includes snoRNA SNORD109A and the SNORD116 cluster of 29 similar
snoRNAs [80,81]. Some of these snoRNAs undergo unusual processing to form chromatin-
associated sno-lncRNAs (snoRNA-related long noncoding RNA) and SPA lncRNAs (50 snoRNA
capped and polyadenylated lncRNA) (Figure 4) [7,8]. The ends of ﬁve 1–3 kb long box C/D sno-
lncRNAs correspond to intronic snoRNAs imbedded in the same intron. Thus, exonucleolytic
degradation of the excised lariat is blocked by assembled snoRNPs that deﬁne mature 50 and 30
sno-lncRNA ends (Figure 4A) [7]. SPA lncRNAs are much longer (34 kb and 16 kb) than sno-
lncRNAs, contain 50 terminal box C/D snoRNPs, and are polyadenylated at the 30 ends [8]. Their
synthesis is splicing-independent and regulated by PAS-dependent transcriptional termination
of the upstream snurf-snrp gene (Figure 4B). Pol II pausing at the proximal snurf-snrp weak PAS
is inefﬁcient and permits polymerase to continue transcription. Still, the nascent RNA is cleaved
by the CPA complex endonuclease at this PAS and the resulting free 50 end is cotranscrip-
tionally digested by the 50-30 exonuclease XRN2. The enzyme moves on until it is physically
blocked by the snoRNP structure downstream of the PAS, thus deﬁning the 50 end of SPA
lncRNA. Pol II proceeds then to the next PAS, where the pre-SPA lncRNA is cleaved,
polyadenylated, and released. The second downstream SPA lncRNA is synthetised in a similar
manner by the still elongating Pol II complex. Both sno-lncRNAs and SPA lncRNAs are not
released to the nucleoplasm, but are retained in the chromatin fraction [7,8]. The internal RNA
sequence, which is protected from degradation by the terminal snoRNP and 30 poly(A) tail for
SPA, is used to sequester splicing factors to ﬁne-tune alternative splicing and thus control gene
expression (Box 3).
SPA lncRNAs are also generated in other genomic localisations. An interplay between NOP56
mRNA and NOP56-derived cytoplasm-located SPA (cSPA) lncRNA acts as a major switch
controlling snoRNA levels in human cells [82]. The NOP56 gene, which encodes essential C/D
core protein, contains several intron-embedded snoRNAs, including an orphan box C/D
snoRD86. A successful snoRD86 assembly into a snoRNP directs alternative splicing of
NOP56 mRNA, which generates snoRD86-cSPA instead of functional mRNA. This decreases
the cellular level of NOP56 protein, which in turn suppresses box C/D snoRNP formation.
Inhibition of snoRD86 maturation allows for correct splicing of NOP56 mRNA, its translation,
and thus box C/D snoRNP synthesis [82].
Unspeciﬁed RNases can further process mammalian snoRNAs to shorter (17–39 nt long)
snoRNA-derived RNA (sdRNA) species [83]. A number of sdRNA exhibit miRNA or piRNA
qualities [13,84,85]. Biogenesis of a subset of sno-miRNAs requires some components of the
canonical miRNA pathway, mainly Dicer for box H/ACA-derived miRNA, or Dicer and DGCR8112 Trends in Genetics, February 2019, Vol. 35, No. 2
Box 3. snoRNA-Related Diseases
Alterations in snoRNA expression and functionality may have severe implications for human health. Many snoRNAs are
linked with carcinogenesis; however, the molecular basis of this association is still obscure. For example, the locus
expressing SNORD50A-SNORD50B is lost in 10–40% of common tumours, including prostate, lung, liver, and skin
cancer [101]. Although both snoRNAs guide methylation of the large ribosome subunit, they also directly bind and inhibit
Ras GTPases and thus act as tumour suppressors [101]. SNORD50A also regulates expression of genes involved in
proliferation and apoptosis by affecting mRNA poly(A) site selection via interaction with the CPA component Fip1 [10].
Moreover, high levels of box C/D snoRNAs are associated with leukaemia and its enhanced self-renewal [102]. The
excess of box C/D snoRNAs may increase rRNA methylation, which in turn may reduce translation ﬁdelity and thus
deregulate gene expression.
Deletion of SNORD109A and the snoRNA genes of the SNORD116 cluster on the paternally inherited chromosome 15
is associated with Prader-Willi syndrome (PWS) [80,81]. PWS is a genetic disorder with a prevalence of 1 in 10 000–
25 000 people [79]. PWS patients display a broad pathological spectrum, including morbid obesity, dysmorphic
changes (e.g., characteristic facial features, hypogonadia, and infertility), behavioural actions (temper tantrums,
stubbornness, compulsive behaviours), and mild intellectual disabilities. Despite the clear connection between PWS
and snoRNA deﬁciency, molecular mechanisms underlying this disease are yet to be uncovered. snoRNAs from the
PWS-related region belong to the orphan snoRNA class. SNORD115 may directly bind and regulate alternative splicing
of a few mRNAs, including serotonin receptor 5HT2CR [103,104]. Moreover, chromatin-associated PWS snoRNA–
lncRNA hybrids, called sno-lncRNAs and SPA lncRNAs (see main text), sequester RNA-binding proteins FOX2, hnRNP
M, and TD43 [7,8]. Interestingly, spliced exons of the snoRNA host ncRNA from the PWS region also accumulate close
to their transcription sites and may also act as molecular sponges [105]. Alternatively, all chromatin-associated ncRNA
may be used as ‘chaperones’ to maintain higher-order chromatin structure [106,107]. Such three-dimensional
chromatin organisation may play crucial roles in the regulation of gene expression [108]. Overall, deletions in the
PWS region, although viable, may lead to minor deregulation of splicing, which, if they accumulate during development,
may manifest as PWS [7,8].for miRNAs processed from both snoRNA classes [86]. Several sno-miRNAs act in RNA
silencing pathways by associating with Argonaute proteins [83]. sno-derived piRNAs may
function in an RNA quality mechanism, as is the case for piR30840 that forms a complex with
Ago4, Piwil4, and TRAMP to target pre-mRNA substrate for exosome-mediated degradation
[13].
snoRNA: A Model ncRNA or an Exception?
Remarkable stability is a distinctive feature of snoRNAs in comparison with other transcripts
generated by Pol II. This is ensured by the compact structure of snoRNAs and their association
with snoRNP proteins. Even so, biogenesis of snoRNAs and some ncRNAs are similar to a
certain extent. This is most apparent in yeast, where several ncRNAs, including snoRNAs,
snRNAs, and unstable transcripts such as cryptic unstable transcripts (CUTs) are terminated
and processed by the same machinery, with the NNS complex playing a pivotal role [22]. It
appears that ncRNA degradation or processing by the NNS-recruited exosome are equivalent
processes, the outcome of which is dictated by the concomitant RNP assembly. RNAs, which
form highly organised secondary structures, like snoRNAs and snRNAs, are protected during
nucleolytic trimming by forming stable RNP structures that halt advancing exonucleases, while
other ncRNAs are fully degraded.
In higher eukaryotes, the majority of transcripts synthesised by Pol II are probably terminated by
CPA factors. Here, processing strategies of snoRNAs and other ncRNAs are in most cases
class-speciﬁc, however, they may share some common features. For example, many ncRNAs,
including snRNAs, eRNAs, and unstable PROMPT RNAs utilise the exosome recruited by the
NEXT/CBCN complex [87]. These factors may contribute to the processing of intronic snoR-
NAs, but they are more likely to act in their quality control and degradation [59]. Synthesis of
other ncRNAs may be more dissimilar. Circular RNAs, circRNAs, and ciRNAs are generated by
back-splicing or inefﬁcient debranching, while MALAT1 and NEAT1 ncRNA contain tRNA-likeTrends in Genetics, February 2019, Vol. 35, No. 2 113
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Figure 4. Unusual Processing of Noncoding RNAs (ncRNAs) Transcribed from the Prader-Willi Syndrome (PWS) Locus. (A) Biogenesis of small nucleolar
RNA (snoRNA)-related long noncoding RNA (lncRNA) (sno-lncRNAs). snoRNP structures in the intron protect the RNA fragment located inbetween snoRNA. (B)
Transcription and processing of 50 snoRNA capped and polyadenylated (SPA) lncRNAs. Cotranscriptionally formed snoRNP blocks the advancing 50-30 exonuclease and
thus affects transcription termination. wPAS, Weak poly(A) site.structures and are processed by tRNA endonucleases RNase P and Z [87–89]. Finally, many
lncRNAs are formed in a fashion similar to mRNAs. However, processing of ncRNAs that are
capped by snoRNA structures (e.g., sno-lncRNAs and SPAs) or contain snoRNA-related motifs
(e.g., telomerase RNA) may employ common elements with the snoRNA maturation machinery
[64–66].
Differences between snoRNA and mRNA are unsurprising since their maturation is generally
governed by distinct mechanisms. In yeast, the common aspects include participation of some
CPA factors and the NNS complex in transcription termination of both RNA classes. The major
components of the termination machinery for protein-coding genes (e.g., CTD-binding protein
Pcf11) cooperate with NNS to enhance Sen1-dependent termination of snoRNA genes.
However, the function of NNS in termination at protein-coding genes is either secondary or
is limited to speciﬁc cases [90]. Also, initial polyadenylation of snoRNA precursors has a
different role than for mRNA, as it serves to stimulate exosome-mediated 30 end processing
and is absent in mature snoRNAs [22]. Finally, involvement of the key snoRNA processing
endo- or exonucleases is limited to Rnt1 activity in fail-safe termination of a few mRNAs [90]. In
vertebrates, biogenesis of mRNA and snoRNA is more disparate. Here, snoRNA synthesis114 Trends in Genetics, February 2019, Vol. 35, No. 2
Outstanding Questions
What is the exact role of the mRNA-
speciﬁc transcription termination and
30 end formation machinery in snoRNA
biogenesis?
Which factors terminate transcription
and process 30 ends of independently
transcribed snoRNAs in human cells?
How important is snoRNA 50 end proc-
essing and why is removal of the m7G
cap important for maturation of box C/
D snoRNAs? What is the exact role of
snoRNA cap hypermethylation? How
has the demand for decapped
snoRNA contributed to the evolution-
ary drive in higher organisms, which
has arranged snoRNA genes in clus-
ters or placed snoRNA in intronic
locations?
How many more unusual snoRNAs,
either encoded in genomic sequences
or generated by alternative process-
ing, are yet to be discovered?
Considering that box C/D and box H/
ACA snoRNAs are structurally distinct
and, at least in S. cerevisiae, have
unrelated processing pathways,
should these two classes be consid-
ered separately in transcriptional
analyses?generally depends on splicing and is hardly considered an independent process, although
some snoRNA hosts are transcribed only to yield snoRNAs. mRNA transcription termination
and 30 end formation factors are unlikely to have any role in biogenesis of intronic snoRNAs. The
activity of PARN and TOE1 deadenylases in snoRNAs 30 end trimming also represents a very
distinctive step [64–66].
Concluding Remarks
In the past decade, it became apparent that up to 90% of the eukaryotic genome is transcribed,
but protein-coding genes comprise only a small fraction (2–3%), with the majority of the
transcriptome consisting of ncRNAs [91]. ncRNAs represent different structural and functional
classes and are regulated by a broad range of processing and decay mechanisms. Although
transcribed by the same RNA polymerase II, snoRNAs and mRNAs have speciﬁc features that
mark them for distinct processing pathways and speciﬁc cellular fate. These hallmarks,
depending on the organism, include cis-acting elements that control their expression via
specialised protein complexes (e.g., the NNS complex in yeast), or the status of their 50 ends,
which determines their processing mode and cellular destination via cap-interacting proteins.
Further research is needed to investigate the interplay between snoRNAs and host mRNA/
lncRNA synthesis in vertebrates (see Outstanding Questions). How often and in which physio-
logical conditions does alternative splicing generate snoRNA–mRNA hybrids and how does this
process regulate expression of the host gene? Moreover, since only a fraction of host mRNAs
and lncRNAs seem to be used as vessels for snoRNA synthesis and are then degraded after
splicing, questions arise concerning the nature of transcriptional switches that decide the fate of
the intronic snoRNAs and the host RNA and how synthesis of the two is coordinated. Finally, 30
end formation of a few essential, independently transcribed snoRNAs in human cells still
remains unclear.
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